RCS - Worldwide Healthcare - Edison issues review on Worldwide Healthcare Trust
12/01/2023 12:17
For best results when printing this announcement, please click on link below: http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230112:nRSL5705Ma&default-theme=true RNS Number : 5705M Worldwide Healthcare Trust PLC 12 January 2023 London, UK, 12 January 2023 Worldwide Healthcare Trust (WWH): Sticking to the successful long-term strategy Worldwide Healthcare Trust's two co-managers, Sven Borho and Trevor Polischuk at specialist investor OrbiMed, remain positive on the prospects for the global healthcare industry. This view is based on favourable company fundamentals, increased clarity on US drug pricing and an upturn in merger and acquisition activity, as pharma companies are using their strong balance sheets to bolster their product pipelines. The trust's portfolio remains skewed to emerging (smaller-cap) biotech and emerging market stocks rather than large-cap pharma companies. While this strategy has been detrimental to WWH's relative performance in recent quarters, this active approach has been successful over the longer term. WWH's 6.1% share price discount to cum-income NAV compares with a 1.2% premium to a 10.6% discount over the last 12 months. It compares with the average discounts of 6.6%, 2.0%, 1.0% and 2.4% over the last one, three, five and 10 years, respectively. If the trust's relative performance improves, there is potential for a higher valuation; prior to Q121 WWH's shares regularly traded close to NAV. Click here (https://www.edisongroup.com/publication/sticking-to-the-successful-long-term-strategy-3/31849/?utm_campaign=RNS%20Press%20Releases&utm_source=RNS&utm_medium=Press%20Release) to view the full report or here (https://share.hsforms.com/1uMgrR7_WSJuk9T81eYT_Gg3k1vq) to sign up to receive research as it is published. All reports published by Edison are available to download free of charge from its website www.edisongroup.com (http://www.edisongroup.com) About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings. Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney. Edison is authorised and regulated by the Financial Conduct Authority (https://register.fca.org.uk/ShPo_FirmDetailsPage?id=001b000000MfYL6AAN) . Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities. For more information, please contact Edison: Mel Jenner +44 (0)20 3681 2500 investmenttrusts@edisongroup.com (mailto:investmenttrusts@edisongroup.com) Learn more at www.edisongroup.com (http://www.edisongroup.com) and connect with Edison on: LinkedIn www.linkedin.com/company/edison-group-/ (http://www.linkedin.com/company/edison-group-/) Twitter www.twitter.com/Edison_Inv_Res (http://www.twitter.com/Edison_Inv_Res) YouTube www.youtube.com/edisonitv (http://www.youtube.com/edisonitv) This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com (mailto:rns@lseg.com) or visit www.rns.com (http://www.rns.com/) . Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy) . END NRABTMTTMTBBBTJ